title: Integration of QbD risk assessment tools and overall risk management.
abstract: Quality by design (QbD) is a global regulatory initiative with the goal of enhancing pharmaceutical development through the proactive design of pharmaceutical manufacturing process and controls to consistently deliver the intended performance of the product. The principles of pharmaceutical development relevant to QbD are described in the ICH guidance documents (ICHQ8-11). An integrated set of risk assessments and related elements developed at Roche/Genentech were designed to provide an overview of product and process knowledge for the production of a recombinant monoclonal antibody. This chapter describes how the risk assessments, logic and interactions of the tools are designed to connect the set of QbD tools and elements into an overarching risk management system. The tools allow comparisons of options based on elective decisions that the sponsor could take and reflect relative values of these options. The overall risk management strategy assures product quality from this enhanced set of assessments and employs a science and risk based approach resulting in a consistent and transparent set of process and product controls and a rational monitoring system.
authors.affiliation: Pharma Technical Development, Genentech, South San Francisco, CA 94080, USA. Electronic address: kelley.brian@gene.com.
authors.forename: Brian
authors.initials: B
authors.lastname: Kelley
authors.affiliation: Pharma Technical Development, Genentech, South San Francisco, CA 94080, USA.
authors.forename: Mary
authors.initials: M
authors.lastname: Cromwell
authors.affiliation: Pharma Technical Development, Genentech, South San Francisco, CA 94080, USA.
authors.forename: Joe
authors.initials: J
authors.lastname: Jerkins
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000737:chemistry / Q000235:genetics / Q000276:immunology / Q000627:therapeutic use; D006801:Humans; D011786:Quality Control; D011994:Recombinant Proteins / Q000737:chemistry / Q000235:genetics / Q000276:immunology / Q000627:therapeutic use; D018570:Risk Assessment / Q000379:methods / Q000592:standards; D017751:Safety Management / Q000379:methods / Q000592:standards
chemical_list: D000911:Antibodies, Monoclonal; D011994:Recombinant Proteins
keywords: Quality by design